AIM
ABMD

Aigen Investment Management’s Abiomed Inc ABMD Stock Holding History

Aigen Investment Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,329
Closed -$338K – 1398
2020
Q1 		$338K Sell
2,329
-2,951
-56% -$490K 0.04% 560
2019
Q4 		$901K Buy
+5,280
New +$979K 0.15% 199

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Aigen Investment Management's ABMD Position: Q2 2020 in Review

Aigen Investment Management sold out of Abiomed Inc (ABMD) in Q2 2020, closing a stake of 2,329 shares — an estimated $338K sold.

Aigen Investment Management first reported a position in ABMD in Q4 2019 and held it in 2 quarters. The position peaked at $901K in Q4 2019. 460 funds tracked by Wall St. Rank hold ABMD as of Q2 2020.

  • Aigen Investment Management reported no remaining Abiomed Inc position as of Q2 2020 after selling out during the quarter.
  • Aigen Investment Management sold 2,329 Abiomed Inc shares in Q2 2020, an estimated $338K.
  • Aigen Investment Management first reported a position in Abiomed Inc in Q4 2019 and held it in 2 quarters.
  • Aigen Investment Management's Abiomed Inc position peaked at $901K in Q4 2019.
  • 460 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2020.

Based on Aigen Investment Management's 13F filing for Q2 2020, filed 10 Aug 2020.